On this page
WDR62
WD repeat domain 62
WDR62 is located on the long (q) arm of chromosome 19, at band 19q13.12. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 19 in the library →Available at Jeen Health
Clinical tests that include this
Overview
WDR62 (WD repeat domain 62) is located on chromosome 19 and encodes a 1,518-amino-acid protein that functions during embryonic brain development. The protein is particularly important for the proliferation and positioning of neural progenitor cells, which give rise to the billions of neurones in the developing brain.
Pathogenic variants in WDR62 cause autosomal recessive primary microcephaly, a neurodevelopmental disorder in which the brain does not grow to its expected size. Affected individuals typically present with a head circumference several standard deviations below the mean at birth, alongside intellectual disability and sometimes additional neurological features. The gene is recognised on multiple NHS Genomic Medicine Service gene panels relating to brain malformations and developmental disorders.
What the gene does
The WDR62 protein is essential for the proper division and migration of neural progenitor cells in the developing cerebral cortex. During embryogenesis, these progenitor cells undergo rapid rounds of division to generate the vast number of neurones required for normal brain architecture. WDR62 localises to the mitotic spindle poles during cell division, where it helps ensure accurate chromosome segregation and correct orientation of the mitotic spindle.
The protein interacts with components of the centrosome, a cellular structure that organises microtubules and coordinates cell division. Research suggests that WDR62 regulates the positioning of the mitotic spindle within dividing neural progenitors, which in turn influences whether these cells divide symmetrically (producing two progenitor cells) or asymmetrically (producing one progenitor and one differentiated neurone). Disruption of this finely tuned process can lead to reduced neurone production and abnormal cortical layering, manifesting as microcephaly and malformations of cortical development.
Video: Genetics 101
Chromosome location
WDR62 is located on the long arm of chromosome 19 at position 19q13.12. The genomic region encompasses multiple exons that together encode the full-length 1,518-amino-acid protein. This chromosomal band contains a cluster of genes, but WDR62 is the specific locus associated with autosomal recessive primary microcephaly in this region.
Protein structure
The WDR62 protein contains thirteen WD repeat domains distributed throughout its length. These repeats include WD 1 (amino acids 109-150), WD 2 (amino acids 153-194), WD 3 (amino acids 196-234), WD 4 (amino acids 291-330), WD 5 (amino acids 357-396), WD 6 (amino acids 402-450), WD 7 (amino acids 490-529), WD 8 (amino acids 532-574), WD 9 (amino acids 578-618), WD 10 (amino acids 626-665), WD 11 (amino acids 671-713), WD 12 (amino acids 714-752), and WD 13 (amino acids 803-846). WD repeats typically form a beta-propeller structure that mediates protein-protein interactions, allowing WDR62 to bind partner proteins involved in spindle assembly and centrosome function. The protein also contains disordered regions at amino acids 762-824 and 908-935, which may provide flexible linkers between structured domains.
Key variants
Pathogenic variants in WDR62 are inherited in an autosomal recessive manner, meaning an individual must inherit two altered copies (one from each parent) to develop the associated condition. Carriers, who have one pathogenic variant and one typical copy, generally do not show features of microcephaly. The variant spectrum includes nonsense, frameshift, and missense changes that disrupt the protein's ability to support normal neural progenitor cell division.
No pathogenic or likely-pathogenic ClinVar variants recorded yet for this gene.
Associated conditions
Variants in WDR62 cause autosomal recessive primary microcephaly, a condition characterised by a head circumference markedly below average from birth. Affected individuals typically have intellectual disability ranging from mild to severe, and some may experience seizures or other neurological manifestations. Brain imaging often reveals simplified gyral patterns (pachygyria) or other cortical malformations, reflecting abnormal neurone production during foetal development. The severity can vary, but most affected individuals require lifelong support for developmental and cognitive challenges.
No condition pages are linked to this gene yet. This does not mean it has no associated conditions.
Inheritance pattern
Conditions caused by pathogenic WDR62 variants typically follow autosomal recessive inheritance.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
UK clinical status
WDR62 is included on several NHS Genomic Medicine Service gene panels. It holds green (high evidence) classification on the DDG2P panel, the Fetal anomalies panel (R21), the Intellectual disability panel (R29), the Malformations of cortical development panel, and the Severe microcephaly panel (R88). These designations reflect strong evidence linking WDR62 variants to neurodevelopmental phenotypes, and the gene may be analysed when relevant clinical features are identified during prenatal or postnatal genetic testing in the NHS.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What does it mean if I am a carrier of a WDR62 variant?
Being a carrier means you have one pathogenic variant and one typical copy of WDR62. Carriers do not typically develop microcephaly or related features, but if both parents are carriers, there is a 25 per cent chance with each pregnancy that a child will inherit two pathogenic variants and be affected.
How is WDR62-related microcephaly diagnosed?
Diagnosis typically involves clinical assessment of head circumference, developmental milestones, and neurological examination, often supported by brain imaging. Genetic testing, including gene panel or exome sequencing, can identify pathogenic variants in WDR62 to confirm the diagnosis.
Is WDR62 tested on the NHS?
WDR62 is included on multiple NHS Genomic Medicine Service gene panels, including those for severe microcephaly, intellectual disability, and cortical malformations. Testing may be arranged through clinical genetics services when a patient's features align with the relevant panel criteria.